All companies › KYMR

KYMR · Kymera Therapeutics, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells6
Research cases0
Last filing2026-10-01

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-10-01 — Mainolfi Nello · sold 3,525 @ $111.44 2026-10-01 — Mainolfi Nello · sold 5,506 @ $112.42 2026-10-01 — Mainolfi Nello · sold 4,876 @ $113.24 2026-10-01 — Mainolfi Nello · sold 7,601 @ $114.43 2026-10-01 — Mainolfi Nello · sold 8,230 @ $115.40 2026-10-01 — Mainolfi Nello · sold 262 @ $116.12
2026-10-012026-10-01

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Mainolfi Nello Chief Executive Officer, Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $KYMR is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-01', 'insider_name': 'Mainolfi Nello', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 3525.0, 'price': 111.44, 'value': 392826.0, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Mainolfi Nello', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 5506.0, 'price': 112.42, 'value': 618984.52, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Mainolfi Nello', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 4876.0, 'price': 113.24, 'value': 552158.24, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Mainolfi Nello', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 7601.0, 'price': 114.43, 'value': 869782.43, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Mainolfi Nello', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 8230.0, 'price': 115.4, 'value': 949742.0, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Mainolfi Nello', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 262.0, 'price': 116.12, 'value': 30423.44, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for KYMR today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.